Japan Precision Psychiatry Market was valued at USD 1.0 Billion in 2022 and is projected to reach USD 2.7 Billion by 2030, growing at a CAGR of 15.0% from 2024 to 2030.
The Japan Precision Psychiatry Market is rapidly growing as an innovative field in mental health, leveraging advanced technologies like AI, machine learning, and genomics to deliver personalized treatments. Precision psychiatry represents a shift from traditional approaches, focusing on individualized care based on a patient’s genetic makeup, lifestyle, and other factors. With a rising awareness of mental health issues in Japan, the demand for precision psychiatry services has surged, providing an opportunity for significant growth in the healthcare sector.
The demand for precision psychiatry services in Japan is influenced by multiple industries. The healthcare industry, including hospitals, clinics, and research institutes, seeks to improve treatment outcomes for patients dealing with mental disorders such as depression, anxiety, and schizophrenia. This demand is met through advanced diagnostic tools and treatment plans tailored to the individual, improving efficacy and minimizing side effects. As more research is done into the genetic factors influencing mental health, these treatments become increasingly effective and widely adopted.
Another key industry contributing to the market’s growth is the pharmaceutical industry. Drug developers are utilizing precision psychiatry to develop medications that are more effective and safer, offering a targeted approach to treating mental health conditions. This has spurred collaborations between pharmaceutical companies and biotech firms, driving innovation in the treatment of psychiatric conditions. Furthermore, technological advancements, including the development of new biomarker-based tests and personalized drug therapies, continue to fuel the market’s expansion.
The increasing adoption of telemedicine and digital health platforms has also had a profound impact on the Japan Precision Psychiatry Market. These technologies enable healthcare providers to offer remote consultations and follow-up care, expanding access to precision psychiatry services across the country. With a rapidly aging population, Japan is seeing a surge in demand for mental health services, which precision psychiatry is well-positioned to address.
In the coming years, the Japan Precision Psychiatry Market is expected to continue expanding as technological advancements evolve and the understanding of mental health deepens. Industries such as healthcare, pharmaceuticals, and technology will continue to drive the demand for more targeted and effective mental health treatments, making precision psychiatry a cornerstone of future psychiatric care.
Get an In-Depth Research Analysis of the Japan Precision Psychiatry Market Size And Forecast [2025-2032]
Â
llumina
Inc
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories
Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
ARUP Laboratories
Invitae Corporation
OPKO Health
Inc.
Laboratory Corporation of America Holdings
Centogene N.V.
Thermo Fisher Scientific Inc.
Myriad Genetics
Inc.
Konica Minolta
Inc.
Fulgent Genetics
PreventionGenetics
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Precision Psychiatry Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Precision Psychiatry Market
Genetic Testing
Biomarker Analysis
Brain Imaging Techniques
Wearable Devices
Artificial Intelligence and Machine Learning Solutions
Depression
Anxiety Disorders
Bipolar Disorder
Schizophrenia
Post-Traumatic Stress Disorder (PTSD)
Clinics
Hospitals
Research Institutes
Pharmaceutical Companies
Home Care Settings
In-person Consultations
Telepsychiatry
Mobile Health Platforms
Remote Monitoring Services
Adults
Pediatric
Elderly
Pregnant Women
Veterans and Active Military Personnel
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan Precision Psychiatry Market Research Analysis
1. Introduction of the Japan Precision Psychiatry Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Precision Psychiatry Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Precision Psychiatry Market, By Type
6. Japan Precision Psychiatry Market, By Application
7. Japan Precision Psychiatry Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan Precision Psychiatry Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/